An immune-cell therapy cleared a child brain cancer in mice
UC San Francisco scientists say engineered immune cells cleared a deadly childhood brain cancer in every mouse tested. The cancer is diffuse midline glioma. The cells only switch on once inside the brain. Nearly all children with it die within a year. The therapy has not been tested in people. A trial could start as early as April 2027.
Where this came from. One outlet reported this. We read it, then wrote the sixty words above.